FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

被引:0
|
作者
M T Cencioni
S Santini
G Ruocco
G Borsellino
M De Bardi
M G Grasso
S Ruggieri
C Gasperini
D Centonze
D Barilá
L Battistini
E Volpe
机构
[1] Neuroimmunology Unit,Department of Biology
[2] Santa Lucia Foundation,Department of Neuroscience ‘Lancisi’
[3] Cell Signaling Unit,Department of Neuroscience
[4] Santa Lucia Foundation,undefined
[5] University Tor Vergata,undefined
[6] Multiple Sclerosis Centre,undefined
[7] Santa Lucia Foundation,undefined
[8] San Camillo Hospital,undefined
[9] University Tor Vergata,undefined
[10] Neuroimmunology and Synaptic Plasticity Unit,undefined
[11] Santa Lucia Foundation,undefined
来源
Cell Death & Disease | 2015年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Functionally distinct T-helper (Th) subsets orchestrate immune responses. Maintenance of homeostasis through the tight control of inflammatory Th cells is crucial to avoid autoimmune inflammation. Activation-Induced Cell Death (AICD) regulates homeostasis of T cells, and it has never been investigated in human Th cells. We generated stable clones of inflammatory Th subsets involved in autoimmune diseases, such as Th1, Th17 and Th1/17 cells, from healthy donors (HD) and multiple sclerosis (MS) patients and we measured AICD. We find that human Th1 cells are sensitive, whereas Th17 and Th1/17 are resistant, to AICD. In particular, Th1 cells express high level of FAS-ligand (FASL), which interacts with FAS and leads to caspases’ cleavage and ultimately to cell death. In contrast, low FASL expression in Th17 and Th1/17 cells blunts caspase 8 activation and thus reduces cell death. Interestingly, Th cells obtained from healthy individuals and MS patients behave similarly, suggesting that this mechanism could explain the persistence of inflammatory IL-17-producing cells in autoimmune diseases, such as MS, where their generation is particularly substantial.
引用
收藏
页码:e1741 / e1741
相关论文
共 50 条
  • [21] The effects of immunosuppressants on FAS-mediated activation-induced cell death in human T lymphocytes
    Fujiwara, T
    Ikeda, Y
    Arita, K
    Kanno, T
    Takehara, Y
    Yabuki, M
    Utsumi, K
    TRANSPLANT INTERNATIONAL, 2003, 16 (02) : 108 - 114
  • [22] Interferon α augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression
    Kaser, A
    Nagata, S
    Tilg, H
    CYTOKINE, 1999, 11 (10) : 736 - 743
  • [23] C-FLIP EXPRESSION DETERMINES LOW SENSITIVITY OF TYPE 17 T HELPER CELLS TO ACTIVATION-INDUCED CELL DEATH
    Yu, Y.
    Idozam, C.
    Anasetti, C.
    Dong, C.
    Yu, X. -Z
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 119 - 119
  • [24] Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice
    Dong, Linlin
    Zheng, Xiaoyu
    Wang, Kun
    Wang, Guonian
    Zou, Huichao
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2018, 85 (03): : 549 - 559
  • [25] Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction
    Porter, BO
    Malek, TR
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (07) : 2360 - 2365
  • [26] Activation-induced and damage-induced cell death in aging human T cells
    Sikora, Ewa
    MECHANISMS OF AGEING AND DEVELOPMENT, 2015, 151 : 85 - 92
  • [27] Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells
    MartinezLorenzo, MJ
    Alava, MA
    Anel, A
    Pineiro, A
    Naval, J
    IMMUNOLOGY, 1996, 89 (04) : 511 - 517
  • [28] Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas
    Ni, X
    Zhang, CL
    Talpur, R
    Duvic, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : 741 - 750
  • [29] Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression
    Oberg, HH
    Sanzenbacher, R
    Lengl-Janssen, B
    Dobmeyer, T
    Flindt, S
    Janssen, O
    Kabelitz, D
    JOURNAL OF IMMUNOLOGY, 1997, 159 (11): : 5742 - 5749
  • [30] Alternation of T-helper 1 and T-helper 2 subsets in peripheral blood cells of patients with multiple sclerosis following autologous haematopoietic stem cells transplantation
    Ouyang, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S146 - S146